Unlocking Insights for Non-Hodgkin Lymphoma Patients with Roche’s cutting-edge cobas EZH2 Mutation test
Peter Schlag's team found that Roche's cobas EZH2 mutation test closely matched next-generation sequencing in detecting EZH2 mutations in samples from people with non-Hodgkin lymphoma.